3-phenyl-2-[4-(2-piperidin-1-ylethoxy)phenyl]-N-(2-pyridin-4-ylethyl)furo[2,3-b]pyridin-4-amine
C33H34N4O2 — CID 11692100
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-phenyl-2-[4-(2-piperidin-1-ylethoxy)phenyl]-N-(2-pyridin-4-ylethyl)furo[2,3-b]pyridin-4-amine
3-phenyl-2-[4-(2-piperidin-1-ylethoxy)phenyl]-N-(2-pyridin-4-ylethyl)furo[2,3-b]pyridin-4-amine (PubChem CID 11692100) has the molecular formula C33H34N4O2 and a molecular weight of 518.66 g/mol. Its IUPAC name is 3-phenyl-2-[4-(2-piperidin-1-ylethoxy)phenyl]-N-(2-pyridin-4-ylethyl)furo[2,3-b]pyridin-4-amine.
Molecular Properties
| Compound Name | 3-phenyl-2-[4-(2-piperidin-1-ylethoxy)phenyl]-N-(2-pyridin-4-ylethyl)furo[2,3-b]pyridin-4-amine |
|---|---|
| PubChem CID | 11692100 |
| Molecular Formula | C33H34N4O2 |
| Molecular Weight | 518.66 g/mol |
| Exact Mass | 518.27 |
| IUPAC Name | 3-phenyl-2-[4-(2-piperidin-1-ylethoxy)phenyl]-N-(2-pyridin-4-ylethyl)furo[2,3-b]pyridin-4-amine |
| SMILES | c1ccc(-c2c(-c3ccc(OCCN4CCCCC4)cc3)oc3nccc(NCCc4ccncc4)c23)cc1 |
| InChI | InChI=1S/C33H34N4O2/c1-3-7-26(8-4-1)30-31-29(35-19-15-25-13-17-34-18-14-25)16-20-36-33(31)39-32(30)27-9-11-28(12-10-27)38-24-23-37-21-5-2-6-22-37/h1,3-4,7-14,16-18,20H,2,5-6,15,19,21-24H2,(H,35,36) |
| InChIKey | RSRIBZZUPWIEDF-UHFFFAOYSA-N |
| XLogP | 7.08 |
| TPSA | 63.42 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 39 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 518.66 |
| LogP ≤ 5 | 7.08 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 11692100 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.